• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Trending:
  • Kashmir
  • Elections
Friday, June 12, 2026

Daily Times

Your right to know

  • HOME
  • Latest
  • Iran-Israel war
  • Gilgit Baltistan Election
  • Pakistan
    • Balochistan
    • Gilgit Baltistan
    • Khyber Pakhtunkhwa
    • Punjab
    • Sindh
  • World
  • Editorials & Opinions
    • Editorials
    • Op-Eds
    • Commentary / Insight
    • Perspectives
    • Cartoons
    • Letters to the Editor
    • Featured
    • Blogs
      • Pakistan
      • World
      • Lifestyle
      • Culture
      • Sports
  • Business
  • Sports
  • E-PAPER
    • Lahore
    • Islamabad
    • Karachi

Nigeria to get nearly 4 mn vaccine doses by August

Published on: June 29, 2021 12:17 PM

Nigeria, Africa’s most populous country, will receive another batch of nearly four million doses of coronavirus vaccines under the Covax scheme by August, a senior health official said Monday.

Covax was set up to ensure equitable distribution of vaccines, particularly to low-income countries, and has already delivered more than 80 million doses to 129 territories. Nigeria — home to some 200 million people — got some four million doses of the AstraZeneca vaccine in March with which it started a nationwide coronavirus vaccination programme. “The federal government has also recently received communication from the Covax facility for additional allocation of 3,924,000 doses of AstraZeneca/AZD1222 vaccine…for delivery into the country by July-August 2021,” Faisal Shuaib of the National Primary Health Care Development Agency told reporters in Abuja. He said the government would also procure 29.8 million doses of the Johnson & Johnson vaccine through the African Union Commission and AfreximBank. “This is expected by September,” he said. “I am glad to inform you that 3,441,146 doses have so far been utilised for the first and second dose vaccinations, which is approximately 88 percent of the total AstraZeneca COVID-19 vaccine stock in the country,” Shuaib said.

He urged those still reluctant to take the jabs to do so. “Let me again assure everyone that reactions are expected from all types of vaccination. COVID-19 vaccine is therefore not an exception,” he said. “What is important is for us to understand that the vaccine is safe and effective and that the reaction would not last,” he said. The virus has killed 2,119 people and infected 167,467 in Nigeria since the first index case in February last year.

Filed Under: World Tagged With: Health, Latest, Nigeria, vaccine, virus

Submit a Comment




Primary Sidebar




Latest News

PTI Internal Dispute

Ali Amin Gandapur Criticizes PTI Statement as ‘Dictatorship’

Karachi Power Outage

Karachi Residents Struggle as Power Outages Continue in Extreme Heat

Hangor-Class Submarine

First China-Built Hangor-Class Submarine Arrives in Karachi

Top African referee Omar Artan to officiate 2026 UEFA Super Cup after being unable to participate in FIFA World Cup 2026.

ODI World Cup 2027 dates announced

Pakistan

PTI Internal Dispute

Ali Amin Gandapur Criticizes PTI Statement as ‘Dictatorship’

Karachi Power Outage

Karachi Residents Struggle as Power Outages Continue in Extreme Heat

Hangor-Class Submarine

First China-Built Hangor-Class Submarine Arrives in Karachi

Agriculture grows 2.89% despite floods

PM Shehbaz approves Pakistan Railways reform roadmap

More Posts from this Category

Business

Khyber pakhtunkhwa budget projected at Rs2.3tr for fiscal year

IMF agrees to drop solar panel tax hike

Pakistan budget 2026-27 unveiled with fiscal targets

Pakistan gold prices drop by over Rs9,000 per tola

Oil prices surge as US-Iran tensions threaten supplies

More Posts from this Category

World

Iran declares April ceasefire meaningless

India demands halt to US ship strikes

Polish president to seek US base deal

More Posts from this Category




Footer

Home
Lead Stories
Latest News
Editor’s Picks

Culture
Life & Style
Featured
Videos

Editorials
OP-EDS
Commentary
Advertise

Cartoons
Letters
Blogs
Privacy Policy

Contact
Company’s Financials
Investor Information
Terms & Conditions

Facebook
Twitter
Instagram
Youtube

© 2026 Daily Times. All rights reserved.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.